This relation of GAS5low status with adverse prognosis is consistent with studies investigating GAS5 in solid tumors, where decrease in GAS5 expression is associated with characteristics of advanced stage tumor, like tumor size and lymph node and distal metastases [33,34]. The gene discussed is GAS5; the disease is neoplasm.